Comparative genomic analysis of drug-resistant and drug-sensitive tuberculosis strains and their impact on cough severity

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Mycobacteria

• Publication date

  2025-11-12

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1186/s44350-025-00008-3
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Dynamic of infectious aerosols generated by cough from patients with pulmonary tuberculosis.

  2025cited by this paper
• The ahpC c−54t compensatory mutation is not always a valid surrogate for isoniazid resistance in Mycobacterium tuberculosis

  2025cited by this paper
• WHO consolidated guidelines on tuberculosis. Module 3

  2025cited by this paper
• Tuberculosis mortality and drug resistance among patients under TB treatment before and during COVID-19 in Burundi: a case–control study

  2025cited by this paper
• The DosR regulon of Mycobacterium avium and adaptation to hypoxia

  2025cited by this paper
• The implications of mutations in multiple genes associated with ethambutol resistance among multidrug-resistant tuberculosis isolates from China

  2025cited by this paper
• Prevalence of katG and inhA mutations associated with isoniazid resistance in Mycobacterium tuberculosis clinical isolates in Cameroon

  2025cited by this paper
• Innovative Strategies for Combating Multidrug-Resistant Tuberculosis: Advances in Drug Delivery Systems and Treatment

  2025cited by this paper
• Factors determining successful treatment outcome among notified tuberculosis patients in Belagavi district of North Karnataka, India

  2024cited by this paper
• Subnational tuberculosis burden estimation for Pakistan

  2024cited by this paper
• Molecular mechanisms of resistance and treatment efficacy of clofazimine and bedaquiline against Mycobacterium tuberculosis

  2024cited by this paper
• Delamanid and bedaquiline resistance patterns in Mycobacterium tuberculosis in Iran: A cross-sectional analysis

  2024cited by this paper
• Mutations in embB406 Are Associated with Low-Level Ethambutol Resistance in Canadian Mycobacterium tuberculosis Isolates

  2024cited by this paper
• Mechanisms of Linezolid Resistance in Mycobacteria

  2023cited by this paper
• Loss-of-function mutations in ndh do not confer delamanid, ethionamide, isoniazid, or pretomanid resistance in Mycobacterium tuberculosis

  2023cited by this paper
• Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study

  2023cited by this paper
• Rv1453 is associated with clofazimine resistance in Mycobacterium tuberculosis

  2023cited by this paper
• Prevalence of Mycobacterium tuberculosis mutations associated with isoniazid and rifampicin resistance: A systematic review and meta-analysis

  2023cited by this paper
• Detection and characterization of mutations in genes related to isoniazid resistance in Mycobacterium tuberculosis clinical isolates from Iran

  2022cited by this paper
• Frequency of rpoB, katG, and inhA Gene Polymorphisms Associated with Multidrug-Resistant Mycobacterium tuberculosis Complex Isolates among Ethiopian TB Patients: A Systematic Review

  2022cited by this paper
• Determination of critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against para-aminosalicylic acid with clinical isolates with thyA, folC and dfrA mutations

  2022cited by this paper
• Bedaquiline: A Novel Diarylquinoline for Multidrug-Resistant Pulmonary Tuberculosis

  2022cited by this paper
• ANALISIS FAKTOR DETERMINAN DEMOGRAFI DENGAN KEJADIAN TUBERCULOSIS MULTIDRUG RESISTANT TUBERCULOSIS (MDR-TB)

  2022cited by this paper
• The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions

  2022cited by this paper
• How Mycobacterium tuberculosis drug resistance has shaped anti-tubercular drug discovery

  2022cited by this paper
• Mechanisms and detection methods of Mycobacterium tuberculosis rifampicin resistance: The phenomenon of drug resistance is complex.

  2021cited by this paper
• Characterization of Mutations Associated with Streptomycin Resistance in Multidrug-Resistant Mycobacterium tuberculosis in Zambia

  2021cited by this paper
• Potential strategies for the management of drug resistant tuberculosis.

  2020cited by this paper
• Characteristics of pulmonary multidrug-resistant tuberculosis patients in Tigray Region, Ethiopia: A cross-sectional study

  2020cited by this paper
• Delamanid resistance: update and clinical management.

  2020cited by this paper
• A systemic review on tuberculosis.

  2020cited by this paper
• Molecular mechanisms of underlying genetic factors and associated mutations for drug resistance in Mycobacterium tuberculosis

  2020cited by this paper
• Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis

  2020cited by this paper
• Mycobacterial ethambutol responsive genes and implications in antibiotics resistance

  2020cited by this paper
• Diagnosis and treatment of multidrug-resistant tuberculosis

  2020cited by this paper
• Mycobacterium tuberculosis Sulfolipid-1 Activates Nociceptive Neurons and Induces Cough

  2020cited by this paper
• Ethambutol

  2020cited by this paper
• Mechanisms of Drug-Induced Tolerance in Mycobacterium tuberculosis

  2020cited by this paper
• Assessing capreomycin resistance on tlyA deficient and point mutation (G695A) Mycobacterium tuberculosis strains using multi-omics analysis.

  2019cited by this paper
• Management of drug-resistant tuberculosis.

  2019cited by this paper
• Linezolid resistance in patients with drug-resistant TB and treatment failure in South Africa

  2019cited by this paper
• Linezolid for drug‐resistant pulmonary tuberculosis

  2019cited by this paper
• GWAS for quantitative resistance phenotypes in Mycobacterium tuberculosis reveals resistance genes and regulatory regions

  2019cited by this paper
• World

  2019cited by this paper
• Profiling Mycobacterium tuberculosis transmission and the resulting disease burden in the five highest tuberculosis burden countries

  2019cited by this paper
• Para-aminosalicylic acid increases the susceptibility to isoniazid in clinical isolates of Mycobacterium tuberculosis

  2019cited by this paper
• Genome-Wide Transcriptional Responses of Mycobacterium to Antibiotics

  2019cited by this paper
• Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan

  2019cited by this paper
• Drug resistance mechanisms and drug susceptibility testing for tuberculosis

  2018cited by this paper
• Interpretation of the mechanism of action of antituberculosis drug bedaquiline based on a novel two‐ion theory of energy coupling in ATP synthesis

  2018cited by this paper
• Mutations in ppe38 block PE_PGRS secretion and increase virulence of Mycobacterium tuberculosis

  2018cited by this paper
• Ecology and evolution of Mycobacterium tuberculosis

  2018cited by this paper
• Mutations inside rifampicin-resistance determining region of rpoB gene associated with rifampicin-resistance in Mycobacterium tuberculosis.

  2018cited by this paper
• Overexpression of eis without a mutation in promoter region of amikacin- and kanamycin-resistant Mycobacterium tuberculosis clinical strain

  2018cited by this paper
• Positive epistasis of major low-cost drug resistance mutations rpoB531-TTG and katG315-ACC depends on the phylogenetic background of Mycobacterium tuberculosis strains.

  2017cited by this paper
• Tuberculosis Infectiousness and Host Susceptibility

  2017cited by this paper
• The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis.

  2017cited by this paper
• Identification of Novel Efflux Proteins Rv0191, Rv3756c, Rv3008, and Rv1667c Involved in Pyrazinamide Resistance in Mycobacterium tuberculosis

  2017cited by this paper
• Analysis of rrs gene mutations in amikacin resistant clinical isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.

  2017cited by this paper
• Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study

  2017cited by this paper
• The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing

  2017cited by this paper
• Mechanistic Principles Behind Molecular Mechanism of Rifampicin Resistance in Mutant RNA Polymerase Beta Subunit of Mycobacterium tuberculosis

  2017cited by this paper
• Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[18F]fluoro-D-glucose positron emission and computed tomography

  2016cited by this paper
• Missense Mutations in the Unfoldase ClpC1 of the Caseinolytic Protease Complex Are Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis

  2016cited by this paper
• Cough Aerosols of Mycobacterium tuberculosis in the Prediction of Incident Tuberculosis Disease in Household Contacts.

  2016cited by this paper
• Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis.

  2016cited by this paper
• Mycobacterium tuberculosis Lineage 4 comprises globally distributed and geographically restricted sublineages

  2016cited by this paper
• Pyrazinamide resistance in Mycobacterium tuberculosis: Review and update.

  2016cited by this paper
• Mutations in rrs, rpsL and gidB in streptomycin-resistant Mycobacterium tuberculosis isolates from Thailand.

  2016cited by this paper
• Vagal Afferent Innervation of the Airways in Health and Disease.

  2016cited by this paper
• Cough and the transmission of tuberculosis.

  2015cited by this paper
• Mechanisms of drug resistance in Mycobacterium tuberculosis: update 2015.

  2015cited by this paper
• Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study

  2015cited by this paper
• Towards tuberculosis elimination: an action framework for low-incidence countries

  2015cited by this paper
• Cough frequency and infectivity in patients with pulmonary tuberculosis.

  2015cited by this paper
• Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis.

  2015cited by this paper
• Mechanisms of Pyrazinamide Action and Resistance

  2014cited by this paper
• Delamanid: A new armor in combating drug-resistant tuberculosis

  2014cited by this paper
• Importance of Cough and M. tuberculosis Strain Type as Risks for Increased Transmission within Households

  2014cited by this paper
• Drug Resistance Mechanisms in Mycobacterium tuberculosis

  2014cited by this paper
• Tuberculosis, pulmonary cavitation, and matrix metalloproteinases.

  2014cited by this paper
• Mycobacterium tuberculosis Strains of the Modern Sublineage of the Beijing Family Are More Likely To Display Increased Virulence than Strains of the Ancient Sublineage

  2014cited by this paper
• Genetic Determinants Involved in p-Aminosalicylic Acid Resistance in Clinical Isolates from Tuberculosis Patients in Northern China from 2006 to 2012

  2014cited by this paper
• Evolution and transmission of drug resistant tuberculosis in a Russian population

  2014cited by this paper
• Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis

  2014cited by this paper
• Evolutionary history of tuberculosis shaped by conserved mutations in the PhoPR virulence regulator

  2014cited by this paper
• para-Aminosalicylic Acid Is a Prodrug Targeting Dihydrofolate Reductase in Mycobacterium tuberculosis♦

  2013cited by this paper
• Novel Mycobacterium tuberculosis Complex Isolate from a Wild Chimpanzee

  2013cited by this paper
• Genomic Analysis Identifies Targets of Convergent Positive Selection in Drug Resistant Mycobacterium tuberculosis

  2013cited by this paper
• Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance

  2013cited by this paper
• Mutations in the embB Gene and Their Association with Ethambutol Resistance in Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates from Poland

  2013cited by this paper
• Costs of tuberculosis disease in the European Union: a systematic analysis and cost calculation

  2013cited by this paper
• Binding Pocket Alterations in Dihydrofolate Synthase Confer Resistance to para-Aminosalicylic Acid in Clinical Isolates of Mycobacterium tuberculosis

  2013cited by this paper
• The Mycobacterium DosR regulon structure and diversity revealed by comparative genomic analysis

  2013cited by this paper
• Biological cost in Mycobacterium tuberculosis with mutations in the rpsL, rrs, rpoB, and katG genes.

  2013cited by this paper
• ESX‐1‐induced apoptosis is involved in cell‐to‐cell spread of Mycobacterium tuberculosis

  2013cited by this paper
• Drug Susceptibility of Mycobacterium tuberculosis Beijing Genotype and Association with MDR TB

  2012cited by this paper
• Disruption of the ESX‐5 system of Mycobacterium tuberculosis causes loss of PPE protein secretion, reduction of cell wall integrity and strong attenuation

  2012cited by this paper
• Effect of Mutation and Genetic Background on Drug Resistance in Mycobacterium tuberculosis

  2012cited by this paper
• Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs.

  2011cited by this paper

• No citing papers are available for this paper.